Shopping Cart 0
Cart Subtotal
AED 0

Krystal Biotech Inc (KRYS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The company's pipeline products include KB103, KB105, and KB200. Its products are used for the treatment of dystrophic EB, TGM1-deficient autosomal recessive congenital ichthyosis, and chronic wounds, among others. The company also utilizes the STAR-D platform to develop treatments for rare orphan dermatological indications caused by the absence of a single gene. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania, the US.

Krystal Biotech Inc (KRYS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Krystal Biotech Raises USD11.25 Million in Venture Financing 10

Private Equity 11

Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11

Equity Offering 12

Krystal Biotech Raises USD69 Million in Public Offering of Shares 12

Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14

Krystal Biotech Raises USD45.54 Million in IPO 15

Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16

Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17

Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18

Debt Offering 19

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19

Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21

Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22

Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23

Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24

Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25

Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26

Acquisition 27

Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27

Krystal Biotech Inc-Key Competitors 28

Krystal Biotech Inc-Key Employees 29

Krystal Biotech Inc-Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Financial Announcements 31

Nov 05, 2018: Krystal Biotech reports third quarter 2018 financial results and provides corporate update 31

Aug 06, 2018: Krystal Biotech announces second quarter 2018 financial results 32

May 07, 2018: Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update 33

Mar 12, 2018: Krystal Biotech Announces 2017 Financial Results 34

Nov 13, 2017: Krystal Biotech Announces Third Quarter 2017 Financial Results 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krystal Biotech Raises USD11.25 Million in Venture Financing 10

Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11

Krystal Biotech Raises USD69 Million in Public Offering of Shares 12

Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14

Krystal Biotech Raises USD45.54 Million in IPO 15

Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16

Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17

Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19

Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21

Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22

Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23

Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24

Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25

Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26

Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27

Krystal Biotech Inc, Key Competitors 28

Krystal Biotech Inc, Key Employees 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Krystal Biotech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The company's pipeline products include KB103, KB105, and KB200. Its products are used for the treatment of dystrophic EB, TGM1-deficient autosomal recessive congenital ichthyosis, and chronic wounds, among others. The company also utilizes the STAR-D platform to develop treatments for rare orphan dermatological indications caused by the absence of a single gene. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania, the US.

Krystal Biotech Inc (KRYS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Krystal Biotech Raises USD11.25 Million in Venture Financing 10

Private Equity 11

Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11

Equity Offering 12

Krystal Biotech Raises USD69 Million in Public Offering of Shares 12

Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14

Krystal Biotech Raises USD45.54 Million in IPO 15

Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16

Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17

Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18

Debt Offering 19

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19

Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21

Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22

Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23

Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24

Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25

Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26

Acquisition 27

Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27

Krystal Biotech Inc-Key Competitors 28

Krystal Biotech Inc-Key Employees 29

Krystal Biotech Inc-Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Financial Announcements 31

Nov 05, 2018: Krystal Biotech reports third quarter 2018 financial results and provides corporate update 31

Aug 06, 2018: Krystal Biotech announces second quarter 2018 financial results 32

May 07, 2018: Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update 33

Mar 12, 2018: Krystal Biotech Announces 2017 Financial Results 34

Nov 13, 2017: Krystal Biotech Announces Third Quarter 2017 Financial Results 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krystal Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krystal Biotech Raises USD11.25 Million in Venture Financing 10

Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11

Krystal Biotech Raises USD69 Million in Public Offering of Shares 12

Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14

Krystal Biotech Raises USD45.54 Million in IPO 15

Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16

Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17

Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19

Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20

Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21

Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22

Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23

Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24

Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25

Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26

Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27

Krystal Biotech Inc, Key Competitors 28

Krystal Biotech Inc, Key Employees 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Krystal Biotech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.